Department of Chemical Engineering, University of California, Santa Barbara, CA 93106, United States.
J Control Release. 2012 Aug 20;162(1):76-83. doi: 10.1016/j.jconrel.2012.05.022. Epub 2012 May 18.
Lysosomes play a critical role in intracellular drug delivery. For enzyme-based therapies, they represent a potential target site whereas for nucleic acid or many protein drugs, they represent the potential degradation site. Either way, understanding the mechanisms and processes involved in routing of materials to lysosomes after cellular entry is of high interest to the field of drug delivery. Most therapeutic cargoes other than small hydrophobic molecules enter the cells through endocytosis. Endocytosed cargoes are routed to lysosomes via microtubule-based transport and are ultimately shared by various lysosomes via tethering and clustering of endocytic vesicles followed by exchange of their contents. Using a combined experimental and numerical approach, here we studied the rates of mass transfer into and among the endocytic vesicles in a model cell line, 3T3 fibroblasts. In order to understand the relationship of mass transfer with microtubular transport and vesicle clustering, we varied both properties through various pharmacological agents. At the same time, microtubular transport and vesicle clustering were modeled through diffusion-advection equations and the Smoluchowski equations, respectively. Our analysis revealed that the rate of mass transfer is optimally related to microtubular transport and clustering properties of vesicles. Further, the rate of mass transfer is highest in the innate state of the cell. Any perturbation to either microtubular transport or vesicle aggregation led to reduced mass transfer to lysosome. These results suggest that in the absence of an external intervention the endocytic pathway appears to maximize molecular delivery to lysosomes. Strategies are discussed to reduce mass transfer to lysosomes so as to extend the residence time of molecules in endosomes or late endosomes, thus potentially increasing the likelihood of their escape before disposition in the lysosomes.
溶酶体在细胞内药物输送中起着至关重要的作用。对于基于酶的疗法,它们代表了一个潜在的靶位;而对于核酸或许多蛋白质药物,它们代表了潜在的降解部位。无论哪种情况,了解细胞内进入后物质向溶酶体的路由的机制和过程,对于药物输送领域都非常重要。除了小的疏水分子之外,大多数治疗性货物都是通过内吞作用进入细胞的。内吞的货物通过基于微管的运输被输送到溶酶体,并最终通过内吞小泡的连接和聚集以及随后交换其内容物,由各种溶酶体共享。在这里,我们使用组合的实验和数值方法,研究了模型细胞系 3T3 成纤维细胞中内吞小泡内和内吞小泡之间的物质转移速率。为了了解物质转移与微管运输和囊泡聚集的关系,我们通过各种药理学试剂改变了这两种性质。同时,通过扩散-对流方程和 Smoluchowski 方程分别对微管运输和囊泡聚集进行了建模。我们的分析表明,物质转移速率与微管运输和囊泡的聚集性质密切相关。此外,在细胞的固有状态下,物质转移速率最高。微管运输或囊泡聚集的任何扰动都会导致向溶酶体的物质转移减少。这些结果表明,在没有外部干预的情况下,内吞途径似乎最大限度地将分子输送到溶酶体。讨论了减少向溶酶体的物质转移的策略,以延长分子在内涵体或晚期内涵体中的停留时间,从而潜在地增加它们在溶酶体中处置之前逃逸的可能性。